The mechanism of the anti-inflammatory activity of mometasone furoate is unclear. Like other topical corticosteroids, it has anti-inflammatory, antipruritic, and vasoconstrictive properties.

Current clinical practice guidelines do not support or refute the use of topical agents for the prevention of ARD. In our pooled analysis of six randomized controlled clinical trials, the use of ...

Mometasone furoate 0.1%. Avoid use near eyes, on face, groin, or axillae. Do not use for diaper dermatitis. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to ...

ESO-101, EsoCap's lead product candidate, consists of a capsule with a rolled-up, thin mucoadhesive film with the anti-inflammatory corticosteroid mometasone furoate. The study was conducted at 14 ...

Current clinical practice guidelines do not support or refute the use of topical agents for the prevention of ARD. In our pooled analysis of six randomized controlled clinical trials, the use of ...

The use of mometasone furoate as a swallowed aerosol ... tract through development of a unique and innovative topical drug delivery platform. Effective topical treatment of the esophagus is ...